This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Andrew Douglas, chief data and analytics officer at Forian Inc. FORA, joined a five-member panel at the Benzinga 2022 Cannabis Capital Conference to discuss the complexities of cannabis legalization and how important access is for patients and consumers who deserve so much more.
Forian optimizes the operational, clinical and financial performance for healthcare, cannabis and the government sector, providing businesses with innovative software solutions, proprietary data and predictive analytics technologies.
Other members of the panel included:
- Nick Kovacevich, CEO of Greenlane Holdings GNLN
- Vahan Ajamian, CPA, CA, CFA, Capital Markets Advisor of High Tide Inc HITI
- Greg Stolowitz, VP Corp Dev and IR of WM Technology Inc MAPS
- Moderator: David Feldman, Co-Founder and CEO of Skip Intro Advisors, LLC.
Watch the full panel discussion below:
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.